Kewaunee Scientific Corporation (KEQU) is a Medical Specialities company listed on NASDAQ. In the last 30 days Quantisnow tracked 2 wire items for KEQU, including 1 M&A update and 1 SEC filing. The most recent was published Nov 2, 2026.
Financial highlights
Full financials- Revenue, TTM
- $277.21M
- Revenue growth
- +5.3%
- Net income, TTM
- $8.23M
- Net margin
- 3.0%
- Free cash flow, TTM
- $10.88M
- Cash
- $8.25M
For the twelve months ended Jul 31, 2026, from SEC filings. Not investment advice.
News · 26 weeks28+100%
2026-05-102026-11-01
Mix990d
- SEC Filings6(67%)
- Other2(22%)
- M&A1(11%)
Latest news
25 items- SECKewaunee Scientific Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure8-K - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
- PRKewaunee Scientific Announces Agreement to Acquire Nycom, Inc.STATESVILLE, N.C., Nov. 2, 2026 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced that it has entered into a definitive agreement to acquire Nycom, Inc. ("Nycom"), the largest lab dealer in the USA. The proposed acquisition represents an important step in Kewaunee's long-term growth strategy, bringing Nycom's expertise in laboratory design and project delivery closer together with Kewaunee's manufacturing capabilities to provide more fully integrated laboratory solutions. The Company intends to leverage Nycom's scalable world-class operating platform to support organic growth and pursue selective acquisition opportunities across North America.
- SECSEC Form 10-Q filed by Kewaunee Scientific Corporation10-Q - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
- SECKewaunee Scientific Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
- PRKewaunee Scientific Reports Results for First Quarter of Fiscal Year 2027STATESVILLE, N.C., Sept. 9, 2026 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced results for its first quarter ended July 31, 2026. Fiscal Year 2027 First Quarter Highlights:Backlog increased to $169.0 million on July 31, 2026, up from $165.9 million on April 30, 2026.International segment net earnings increased 23.5% and segment EBITDA increased 13.9% despite lower sales as a result of a favorable mix of higher-margin projects.Ongoing cost management efforts and improved operating efficiencies helped mitigate the negative impact of lower manufacturing volumes within LPG.Higher effective tax rate d
- SECKewaunee Scientific Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
- SECKewaunee Scientific Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
- SECKewaunee Scientific Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
- PRKewaunee Scientific to Report Results for First Quarter Fiscal Year 2027STATESVILLE, N.C., Aug. 25, 2026 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced that the Company plans to release its first quarter fiscal year 2027 financial results on Wednesday, September 9, 2026 after the close of trading. This information will be available on the Company's website www.kewaunee.com after the release. About Kewaunee Scientific Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The Company's portfolio includes laboratory casework, fume hoods, adap
- SECSEC Form DEFA14A filed by Kewaunee Scientific CorporationDEFA14A - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
- SECSEC Form DEF 14A filed by Kewaunee Scientific CorporationDEF 14A - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
- INSIDERSVP, People & Culture Phillips Elizabeth D converted options into 6,656 shares, returned $181,069 worth of shares to the company (4,995 units at $36.25) and covered exercise/tax liability with 793 shares, increasing direct ownership by 11% to 9,116 units (SEC Form 4)4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- INSIDERSVP, IT & Engineering Ranade Mandar converted options into 7,227 shares, returned $65,250 worth of shares to the company (1,800 units at $36.25) and covered exercise/tax liability with 1,877 shares, increasing direct ownership by 28% to 16,215 units (SEC Form 4)4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- INSIDERSVP, Sales & Marketing Dev Noble Ryan S. returned $108,750 worth of shares to the company (3,000 units at $36.25), covered exercise/tax liability with 1,809 shares and converted options into 7,206 shares, increasing direct ownership by 17% to 16,240 units (SEC Form 4)4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- INSIDERSVP, Manufacturing Operations Batdorff Douglas J. converted options into 7,451 shares, returned $203,326 worth of shares to the company (5,609 units at $36.25) and covered exercise/tax liability with 851 shares, increasing direct ownership by 14% to 8,170 units (SEC Form 4)4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- INSIDERChief Financial Officer Gardner Donald T. Iii converted options into 21,265 shares, returned $435,000 worth of shares to the company (12,000 units at $36.25) and covered exercise/tax liability with 4,027 shares, increasing direct ownership by 55% to 14,802 units (SEC Form 4)4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- INSIDERPresident & CEO Hull Thomas David Iii converted options into 54,388 shares, returned $616,250 worth of shares to the company (17,000 units at $36.25) and covered exercise/tax liability with 16,243 shares, increasing direct ownership by 64% to 54,145 units (SEC Form 4)4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- SECSEC Form 10-K filed by Kewaunee Scientific Corporation10-K - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
- INSIDERSEC Form 4 filed by SVP, People & Culture Phillips Elizabeth D4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- INSIDERSEC Form 4 filed by SVP, IT & Engineering Ranade Mandar4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- INSIDERSEC Form 4 filed by SVP, Sales & Marketing Dev Noble Ryan S.4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- INSIDERSEC Form 4 filed by SVP, Manufacturing Operations Batdorff Douglas J.4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- INSIDERSEC Form 4 filed by Chief Financial Officer Gardner Donald T. Iii4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- INSIDERSEC Form 4 filed by President & CEO Hull Thomas David Iii4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- SECKewaunee Scientific Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
KEQU FAQ
9 questionsWhat does Kewaunee Scientific Corporation do?
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. It operates in two segments, Domestic and International. The company's products include steel, wood, laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services. Its laboratory products are used in chemistry, physics, biology, and other general science laboratories in the...What is the latest news on KEQU?
In the last 30 days Quantisnow tracked 2 wire items for KEQU: 1 M&A update and 1 SEC filing. The most recent was published on November 2, 2026.What is KEQU revenue?
Kewaunee Scientific Corporation (KEQU) reported $277.21M of revenue for the twelve months ended Jul 31, 2026. That is up 5.3% from the year before. Revenue for fiscal 2026 was $282.00M.Is KEQU profitable?
Yes. Kewaunee Scientific Corporation earned $8.23M in net income for the twelve months ended Jul 31, 2026, a net margin of 3.0%.How much cash and debt does KEQU have?
Kewaunee Scientific Corporation reported $8.25M in cash and cash equivalents and $18.83M of debt on its most recent balance sheet in SEC filings.Where does KEQU stock trade?
Kewaunee Scientific Corporation (KEQU) is listed on NASDAQ.What sector and industry is KEQU in?
Kewaunee Scientific Corporation operates in the Industrials sector, Medical Specialities industry.What companies are similar to KEQU?
Notable peers in the same industry include UNH (UnitedHealth Group Incorporated), ELV (Elevance Health Inc.), CI (The Cigna Group), NTRA (Natera Inc.), HUM (Humana Inc.). Compare KEQU side-by-side with any of them on Quantisnow.How can I track KEQU on Quantisnow?
Quantisnow aggregates Kewaunee Scientific Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow KEQU to receive live email and push alerts on every new disclosure.